Amgen ٢٨ أبريل ٢٠٢٦ FDA turns up heat on Amgen, proposing to rescind approval of Tavneos - Fierce Pharma
Amgen ٢٤ أبريل ٢٠٢٦ Amgen’s Chief Technology Officer Dr David Reese to retire - European Pharmaceutical Review
Amgen ٢٠ أبريل ٢٠٢٦ Zurcher Kantonalbank Zurich Cantonalbank Buys 55,333 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen ٢٠ أبريل ٢٠٢٦ Pfizer, Amgen among 22 firms to expand in Hong Kong: SCMP (PFE:NYSE) - Seeking Alpha
Amgen ١٦ أبريل ٢٠٢٦ Federal Circuit Distinguishes Amgen in Reversal of Invalidation of Teva Headache Treatment Patents - IPWatchdog.com
Amgen ١٥ سبتمبر ٢٠٢٥ Global biotech leaders Amgen and Gilead announcing expansions in California, the #1 state for life sciences - California State Portal | CA.gov